Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $90.00

Acadia Healthcare (NASDAQ:ACHC - Free Report) had its price target lowered by Bank of America from $105.00 to $90.00 in a research report sent to investors on Thursday, Benzinga reports. Bank of America currently has a buy rating on the stock.

ACHC has been the subject of several other reports. Barclays lowered their target price on shares of Acadia Healthcare from $100.00 to $91.00 and set an overweight rating for the company in a research note on Thursday. Cantor Fitzgerald reaffirmed a neutral rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a sell rating to a hold rating and set a $70.00 target price for the company in a research note on Thursday, April 25th. Royal Bank of Canada reaffirmed an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Monday, March 4th. Finally, TheStreet raised shares of Acadia Healthcare from a c rating to a b- rating in a research note on Monday, March 4th. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus price target of $90.90.

Acadia Healthcare Price Performance

Shares of ACHC traded down $6.26 during mid-day trading on Thursday, reaching $66.73. 2,802,918 shares of the company's stock were exchanged, compared to its average volume of 597,348. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. The company has a 50-day simple moving average of $77.49 and a two-hundred day simple moving average of $77.68. Acadia Healthcare has a 52-week low of $66.39 and a 52-week high of $87.77. The company has a market cap of $6.17 billion, a price-to-earnings ratio of -269.63, a PEG ratio of 2.18 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Wednesday, May 1st. The company reported $0.84 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business had revenue of $768.10 million during the quarter, compared to analysts' expectations of $779.20 million. During the same period last year, the company posted $0.75 EPS. The company's revenue was up 9.1% on a year-over-year basis. On average, sell-side analysts predict that Acadia Healthcare will post 3.57 EPS for the current fiscal year.

Insider Activity at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC acquired a new position in Acadia Healthcare in the 4th quarter worth $26,000. Headlands Technologies LLC acquired a new position in Acadia Healthcare in the 3rd quarter worth $25,000. Mather Group LLC. acquired a new position in Acadia Healthcare in the 1st quarter worth $48,000. Fifth Third Bancorp lifted its holdings in Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company's stock worth $52,000 after buying an additional 136 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Acadia Healthcare in the 3rd quarter worth about $96,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.